Cosmo Bio Company,Limited (3386.T)
JPY 1169.0
(0.6%)
JPY 1169.0
(0.6%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -2.8 Billion JPY | 6.96% |
| 2022 | -3.01 Billion JPY | 6.77% |
| 2021 | -3.23 Billion JPY | -3.06% |
| 2020 | -3.13 Billion JPY | -31.01% |
| 2019 | -2.39 Billion JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -2.69 Billion JPY | 3.99% |
| 2024 Q2 | -2.6 Billion JPY | -11.54% |
| 2023 Q3 | -3.41 Billion JPY | 8.41% |
| 2023 Q1 | -2.9 Billion JPY | 3.65% |
| 2023 Q2 | -3.73 Billion JPY | -28.42% |
| 2023 FY | -2.8 Billion JPY | 6.96% |
| 2023 Q4 | -2.8 Billion JPY | 17.91% |
| 2022 Q3 | -3.21 Billion JPY | 0.0% |
| 2022 FY | -3.01 Billion JPY | 6.77% |
| 2022 Q4 | -3.01 Billion JPY | 6.07% |
| 2021 FY | -3.23 Billion JPY | -3.06% |
| 2020 FY | -3.13 Billion JPY | -31.01% |
| 2019 FY | - JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Shin Nippon Biomedical Laboratories, Ltd. | 16.05 Billion JPY | 117.476% |
| DNA Chip Research Inc. | -388.4 Million JPY | -622.44% |
| H.U. Group Holdings, Inc. | 41.99 Billion JPY | 106.681% |
| FALCO HOLDINGS Co., Ltd. | -9.24 Billion JPY | 69.658% |
| BML, Inc. | -68.84 Billion JPY | 95.924% |
| Human Metabolome Technologies, Inc. | -1.56 Billion JPY | -79.618% |
| Precision System Science Co., Ltd. | -548.58 Million JPY | -411.496% |